These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25335496)

  • 1. Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects.
    Wessels MW; Herkert JC; Frohn-Mulder IM; Dalinghaus M; van den Wijngaard A; de Krijger RR; Michels M; de Coo IF; Hoedemaekers YM; Dooijes D
    Eur J Hum Genet; 2015 Jul; 23(7):922-8. PubMed ID: 25335496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
    Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene.
    Lekanne Deprez RH; Muurling-Vlietman JJ; Hruda J; Baars MJ; Wijnaendts LC; Stolte-Dijkstra I; Alders M; van Hagen JM
    J Med Genet; 2006 Oct; 43(10):829-32. PubMed ID: 16679492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of an infant with compound heterozygous mutations for hypertrophic cardiomyopathy producing a phenotype of left ventricular noncompaction.
    Haberer K; Buffo-Sequeira I; Chudley AE; Spriggs E; Sergi C
    Can J Cardiol; 2014 Oct; 30(10):1249.e1-3. PubMed ID: 25262865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing (NGS) as a molecular diagnostic tool for hypertrophic cardiomyopathy in a Chinese boy due to novel compound heterozygous mutations in the MYBPC3 gene: A case report.
    Chen X; Jiang J; Zhu W; Wu Y; Su M
    Medicine (Baltimore); 2019 Mar; 98(12):e14676. PubMed ID: 30896616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing (NGS) as a fast molecular diagnosis tool for left ventricular noncompaction in an infant with compound mutations in the MYBPC3 gene.
    Schaefer E; Helms P; Marcellin L; Desprez P; Billaud P; Chanavat V; Rousson R; Millat G
    Eur J Med Genet; 2014 Mar; 57(4):129-32. PubMed ID: 24602869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology.
    Olson TM; Karst ML; Whitby FG; Driscoll DJ
    Circulation; 2002 May; 105(20):2337-40. PubMed ID: 12021217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound heterozygosity deteriorates phenotypes of hypertrophic cardiomyopathy with founder MYBPC3 mutation: evidence from patients and zebrafish models.
    Hodatsu A; Konno T; Hayashi K; Funada A; Fujita T; Nagata Y; Fujino N; Kawashiri MA; Yamagishi M
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1594-604. PubMed ID: 25281569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.
    Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V
    Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathy.
    Helms AS; Davis FM; Coleman D; Bartolone SN; Glazier AA; Pagani F; Yob JM; Sadayappan S; Pedersen E; Lyons R; Westfall MV; Jones R; Russell MW; Day SM
    Circ Cardiovasc Genet; 2014 Aug; 7(4):434-43. PubMed ID: 25031304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of compound mutations in the MYBPC3 gene associated with biventricular hypertrophy and neonatal death.
    Marziliano N; Merlini PA; Vignati G; Orsini F; Motta V; Bandiera L; Intrieri M; Veronese S
    Neonatology; 2012; 102(4):254-8. PubMed ID: 22907696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
    Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
    Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene.
    Hallıoğlu Kılınç O; Giray D; Bişgin A; Tuğ Bozdoğan S; Karpuz D
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):450-453. PubMed ID: 28694399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
    Richard P; Charron P; Carrier L; Ledeuil C; Cheav T; Pichereau C; Benaiche A; Isnard R; Dubourg O; Burban M; Gueffet JP; Millaire A; Desnos M; Schwartz K; Hainque B; Komajda M;
    Circulation; 2003 May; 107(17):2227-32. PubMed ID: 12707239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.